Global Snoring Control Device Market Size By Type (Nasal Devices, Oral Appliances), By Application (Pharmaceutical Companies, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

lobal Snoring Control Device Market Report Description

The Global Snoring Control Device Market was valued at USD 1.4 billion in 2023 and is projected to reach USD 2.5 billion by 2031, growing at a CAGR of 7.5% during the forecast period of 2023-2031. Increasing awareness about sleep disorders, rising prevalence of conditions such as obstructive sleep apnea, and growing demand for non-invasive snoring solutions are major factors driving the market growth. Advancements in device technologies and the rising adoption of online retail channels are further propelling the market forward.

Drivers:

Rising Prevalence of Sleep Disorders:

The global increase in sleep disorders, particularly snoring and sleep apnea, is a major growth driver. The demand for effective, non-invasive solutions is pushing individuals to opt for snoring control devices.

Technological Innovations in Devices:

Continuous innovations such as smart anti-snoring devices, wearable nasal dilators, and Bluetooth-enabled sleep trackers are enhancing user experience, boosting market demand.

Growing Awareness of Health Risks Associated with Snoring:

Snoring is increasingly recognized as a symptom of underlying health issues like heart disease and diabetes. Growing public health initiatives and awareness campaigns are fostering market growth.

Restraints:

High Cost of Advanced Devices:

Premium snoring control devices with advanced technology features tend to be costly, limiting adoption among price-sensitive consumers.

Limited Effectiveness for Severe Cases:

Non-invasive snoring control devices may be less effective for individuals with severe obstructive sleep apnea, which may restrict their overall usage.

Opportunity:

Emerging Demand in Developing Regions:

Developing economies, particularly in Asia-Pacific and Latin America, present untapped potential due to increasing health awareness and improving healthcare infrastructure.

Expansion of Online Retail Platforms:

The surge in e-commerce platforms has made it easier for consumers to access a wide range of snoring control devices, opening new growth opportunities for market players.

Market by System Type Insights:

Based on system type, the Mandibular Advancement Devices (MADs) segment accounted for the largest market share in 2023. These devices are popular due to their proven effectiveness and comfort. However, the Tongue Stabilizing Devices (TSDs) segment is projected to witness the fastest growth rate due to increasing consumer preference for less intrusive solutions.

Market by End-use Insights:

By end-use, the Homecare Settings segment emerged as the dominant market segment in 2023. The convenience and cost-effectiveness of using snoring control devices at home are driving this segment's growth. Clinics and sleep centers also represent a significant share, owing to the rising number of professional treatments available.

Market by Regional Insights:

Geographically, North America dominated the global snoring control device market in 2023, primarily due to high awareness levels, sophisticated healthcare infrastructure, and the strong presence of leading players. Meanwhile, Asia-Pacific is expected to exhibit the highest CAGR during the forecast period, driven by increasing health consciousness, urbanization, and expanding middle-class income groups.

Competitive Scenario:

Key players operating in the global snoring control device market include ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, SomnoMed Limited, ZQuiet, SnoreRx, Airway Management Inc., Theravent, Rhinomed Limited, Tomed GmbH, and Apnea Sciences Corporation. These companies are focusing on strategic product launches, partnerships, and geographic expansions to enhance their market presence.

Recent Developments:

In 2023, ResMed Inc. introduced an updated version of its mobile-connected mandibular advancement device, enhancing real-time monitoring capabilities.

In 2024, Fisher & Paykel Healthcare expanded its product line by launching an innovative nasal dilator targeted at light and moderate snorers.

In 2025, ZQuiet partnered with a major online pharmacy chain to expand the availability of its devices in emerging markets.

Scope of Work – Global Snoring Control Device Market

Report Metric Details

Market Size (2023) USD 1.4 billion

Projected Market Size (2031) USD 2.5 billion

CAGR (2023-2031) 7.5%

Key Segments by System